Navigation Links
Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent
Date:3/18/2008

nable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at http://www.gehealthcare.com.

ABOUT MYOVIEW, SELECT SAFETY INFORMATION

Myoview(TM) (technetium Tc-99m Tetrofosmin) In studying patients with known or suspected coronary artery disease, care should be taken to ensure continuous cardiac monitoring and the availability of emergency cardiac treatment. As with all injectable drug products, allergic reactions and anaphylaxis may occur. Pharmacologic induction of cardiovascular stress may be associated with serious adverse events such as myocardial infarction, arrhythmia, hypotension, bronchoconstriction, and cerebrovascular events. Caution should be used when pharmacologic stress is selected as an alternative to exercise; it should be used when indicated and in accordance with the pharmacologic stress agent's labeling. The most common adverse reactions reported from post-marketing experience with Myoview included rash, urticaria, abnormal vision, allergic reactions, and fever.

Before use of the product please refer to the product's full prescribing information, available at
'/>"/>

SOURCE GE Healthcare; Cardinal Health
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
2. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
3. Cardinal Health To Announce First-Quarter Results on November 5
4. Cardinal Health Announces Sector Management Change
5. Cardinal Health Reports First Quarter Results
6. Cardinal Health, Sentry Data Systems Introduce New Technology to Help Health Care Providers More Cost-Efficiently Care for Underserved
7. Cardinal Health Receives DEA Order to Temporarily Cease Distribution of Controlled Substances from Auburn, Wash. Facility
8. Cardinal Health Foundation Grants $537,000 to Rural, Public Hospitals in Support of IHIS 5 Million Lives Campaign
9. Cardinal Health to Cease Distribution of Controlled Substances from Florida Facility
10. Cardinal Health to Announce Second-Quarter Results on January 29
11. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...wcasing Innovative Health Product in Scottsdale ,...-- A valley inventor garnering national attention ...weight, prevent disease, restore health, improve m...product at Saturday’s Technology Fair locate... has been featured on major television networks ac...
(Date:12/4/2009)...ewswire/ -- As Congress prepares to vote on a heal...C) today announced an eight week campaign to call ...ousehold on provisions of the Senate health care b...igher taxes, and government-run health care, or th...opposition to the so-called health care reform wil...
(Date:12/4/2009)...ewswire/ -- Farmers Insurance Missouri State Execu...ndy Cole, and Brad Ballard, the CEO and creator of...mers called FireFacts , will conduct a childr...ber 9. ,, (Logo: http://www.newscom.com/cgi...ire safety comes following a tragic fire that took...
(Date:12/4/2009)...al of Neurosurgery: Pediatrics finds that operati...ma, or JPA, tumors in the thalamus of the brain ca...TI. The sensitivity of DTI imaging allows for the.... This information can maximize the potential of ...e to the fiber bundles that are directly related t...
(Date:12/4/2009)...ng manufacturer of over-the-counter topical cream ...rs’ quality of life, today announced that it...edical Association (APMA) Seal of Approval for its... (PRWEB) December 4, 2009 ...e-counter topical cream and first aid products des...
Breaking Medicine News(10 mins):Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2Health News:FRC Announces Campaign to Call Every Louisiana Household, Urging Opposition to Health Care Takeover 2Health News:Missouri Safety Day at the Capitol 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4
...tic manipulation poses, study finds , , TH...ve converted adult cells into embryonic-like stem ...etic manipulation. , Gene manipulation is an older...ally altering them could lead to the development o...
...nerve damage while performing a robotic assisted l...om becoming impotent, according to a study perform...A. , Preoperative MR was used to evaluate 38 neu... Timothy McClure, MD, lead author of the study. "1...
...redict, with a high degree of confidence, whether ...oscopy or removed through polypectomy, according t... School of Medicine and Public Health in Madison, ...p is found with CT colonography, a corresponding p...
..., which usually indicates prior exposure to tuberc...t typically includes a frontal and lateral view. T...al radiation dose during screening, is not necessa...taken in 857 patients with positive PPD (tuberculo...
... following 62-cent increase on cigarettes , , MIN...e on cigarettes has a lot of Minnesotans trying to...oking program provided by ClearWay Minnesota(SM), ...h Insurance Program (SCHIP). , , (Logo: http://...
... 10 Seconds to Care: Help and Hope for Busy Clinic...ishing program of the American College of Physicia...and advice about the healing power of compassionat...and other health care professionals, the timing fo...
Other Medicine News:Health News:Scientists Find New Way to Create Stem Cells 2Health News:Minnesota Smokers Turning to QUITPLAN(R) Services After Cigarette Tax Hike 2Health News:Minnesota Smokers Turning to QUITPLAN(R) Services After Cigarette Tax Hike 3Health News:'Only 10 Seconds to Care' by Dr. Wendy S. Harpham helps heal clinician-patient bonds 2
(Date:12/4/2009)... , BILLERICA, Mass., Dec. 4 /PRNewswire-...wned subsidiary of Volcano Corporation (Nasdaq: V... successful testing of a novel integrated light so... this proprietary optical engine design raises the...mitations of laser-based designs for swept source ...
(Date:12/4/2009)... , TARRYTOWN, N.Y., Dec. 4 /PRNewswire/ ...rand prize winners of Bayer,s "Express Your Simple... Brothers, selected the winning video entries subm...untry. The grand prize is an in-person meeting tod... diabetes like Nick, are: Caleb, age 6, from Danbu...
(Date:12/4/2009)... , WILMINGTON, Del., Dec. 4 /PRNewswire-Fir...ced that the US Food and Drug Administration (FDA)...pine fumarate) Extended Release Tablets as adjunct...s with Major Depressive Disorder (MDD). SEROQUEL X...the FDA to treat both major depressive disorder as...
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results 13409 1Micromet Inc Reports Second Quarter 2009 Financial Results 53819 1Micromet Inc Reports Second Quarter 2009 Financial Results 53819 2Micromet Inc Reports Second Quarter 2009 Financial Results 53819 3Micromet Inc Reports Second Quarter 2009 Financial Results 53819 4Micromet Inc Reports Second Quarter 2009 Financial Results 53819 5Micromet Inc Reports Second Quarter 2009 Financial Results 53819 6Micromet Inc Reports Second Quarter 2009 Financial Results 53819 7Micromet Inc Reports Second Quarter 2009 Financial Results 53819 8Micromet Inc Reports Second Quarter 2009 Financial Results 53819 9Micromet Inc Reports Second Quarter 2009 Financial Results 53819 10Micromet Inc Reports Second Quarter 2009 Financial Results 53819 11Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 1Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 2Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 3Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 4Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 5Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 6Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 7
...ntisense Drug Targeting Glucagon Receptor for Trea..., CARLSBAD, Calif., Oct. 2 Isis,Pharmaceuticals,...ed $5,million from Ortho-McNeil, Inc. (OMI), a Joh...velopment milestone of initializing the Phase 1,cl...tween Isis and OMI, announced on September 13,2007...
...ority Studies versus Hepsera(R) in Patients with C...Studies will also Assess Clevudine,s Sustained Vir... HBV-, PRINCETON, N.J., Oct. 1 Pharmasset...ase 3 registration clinical trials,of clevudine fo...,infection. Clevudine is an oral, once-daily pyrim...
Other Medicine Technology:Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568 2Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568 3Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV 2Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV 3Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV 4Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV 5
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: